Treating pediatric PTSD with memory reactivation and propranolol
Official title: Treatment of Pediatric Post-traumatic Stress Disorder With Memory Reactivation Under the Influence of Propranolol: A Randomized Placebo-controlled Trial. PPP
Run by University Hospital, Toulouse · NCT04985344 · Data updated 2026-11-12
This study is testing if giving children with PTSD a medication called propranolol along with special memory exercises can help lessen the emotional pain from their traumatic memories.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 7 Years to 12 Years |
| Sex | All |
| Enrollment | 92 (estimated) |
| Sponsor | University Hospital, Toulouse Academic / other |
| Locations | 1 site (Toulouse) |
| Status | Recruiting |
| Started | February 1, 2023 |
| Main results expected | September 2027 |
| Study ends | September 2027 |
| Registry record updated | August 28, 2023 |
| Trial ID | NCT04985344 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are children aged 7-12 years who have been diagnosed with PTSD for at least six months.
✕Probably not a fit
Patients younger than 7 or older than 12 years, or those with contraindications to propranolol, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the effectiveness of propranolol, a beta-blocker, in conjunction with memory reactivation techniques to treat pediatric post-traumatic stress disorder (PTSD) in children aged 7-12. The study aims to disrupt the reconsolidation of traumatic memories, potentially reducing the emotional impact of these memories. Participants will receive either propranolol or a placebo while undergoing memory reactivation sessions. The trial seeks to provide a novel approach to treating PTSD in children, where traditional therapies may lead to high dropout rates due to the intensity of re-experiencing trauma.
Why it matters
Potential benefit: If successful, this approach could offer a new, effective treatment option for children suffering from PTSD.
How similar studies have gone: While traditional trauma-focused therapies have shown some success, the use of propranolol in this context is a novel approach that has not been extensively tested in pediatric populations.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Children aged 7-12 years * CPTS-RI total score ≥40 * Primary diagnosis of PTSD (6 months or more after the traumatic event) * Heart rate ≥ 55 bpm * Systolic blood pressure ≥ 95 mm Hg * Affiliation to a social security scheme * Written consent signed by the parents/holders of parental authority and the investigator * Acceptance of the protocol by the child-Child and Parents/Holders of parental authority fluent in French Exclusion Criteria: * Age\<7 years or ≥13 years * Children whose parents have been deprived of their authority * Contraindication to propranolol (cardiogenic shock, sinus bradycardia, hypotension (\< fifth percentile oscillometric or \<2SD) (Banker et al., 2016 - see APPENDIX 1), greater than first-degree heart block, heart failure, bronchial asthma and hypersensitivity to propranolol hydrochloride) * Concurrent medication with possible interactions with propranolol (cf 8.2) * Concurrent psychotropic drugs that have been shown to be effective in improving symptoms of PTSD (Antidepressants, atypical antipsychotics, mood stabilizers) * Concurrent psychotherapy (\>1 structured session/month declared by the clinician who follows the child) * Current active psychosis, anorexia nervosa, bulimia nervosa, binge-eating disorder, attention-deficit hyperactivity disorder, autism spectrum disorder * Children with psoriasis * Children with a predisposition to hypoglycemia * Obsessive-compulsive disorders * Bipolar Disorders * Mental retardation, * Traumatic brain injury (loss of consciousness \> 10 minutes) * Currently treated with a bradycardic drug * Concurrent participation to another interventional study * Renal or Hepatic Impairment * Pregnancy
Where it's running
-
Toulouse University Hospital
Toulouse, France Recruiting
Study contacts
- Principal investigator: Philippe Birmes, PH — University Hospital, Toulouse
- Study coordinator: Philippe Birmes, PH
- Email: birmes.p@chu-toulouse.fr
- Phone: 05 34 55 75 00
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Hyperbaric Oxygen Therapy for Veterans With TBI and PCS
This study tests whether 40 HBOT sessions can change blood biomarkers in veterans with traumatic brain injury and persistent symptoms, and whether PTSD affects those biomarker changes.
-
Internet-delivered ACT for youth with PTSD and chronic pain
A small pilot study will test a web-based Acceptance and Commitment Therapy program for teens and young adults with PTSD and chronic pain to see if it helps with symptoms and functioning.
-
Reboxetine plus Ritalin vs Dog-Assisted Therapy for PTSD
This study tests whether a drug combo of reboxetine and methylphenidate works better than dog-assisted therapy for people with PTSD.
-
Floatation-REST for frontline workers with post-traumatic stress symptoms
This early pilot tests whether two 60-minute Floatation-REST sessions can be safely tried by frontline healthcare workers and first responders who have post-traumatic stress symptoms, compared to watching a documentary.
-
Short-Term Intensive PTSD Treatment for Military Personnel
This trial tests whether a brief, massed form of CPT and EMDR can quickly reduce PTSD symptoms and related cognitive problems in active-duty military personnel.
-
Exposure by Assessment: Testing AMQ-based EMA on Intrusive Trauma Memories in PTSD
We’re testing whether daily prompts to focus on a traumatic memory (vs. a neutral memory) using a simple at-home EMA can reduce intrusive PTSD memories and overall PTSD symptoms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.